This issue of Rheumatic Disease Clinics, guest edited by Dr. Alfred Kim and Zahi Touma, will discuss a number of key topics surrounding Lupus. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: Interferons in SLE, NETosis and neutrophils in SLE, AMP update in lupus nephritis, Patient-reported outcomes, Complement, T cells in SLE, B cells in SLE, Outcome measures for SLE clinical trials, Mitochondrial physiology in SLE, Pregnancy, Lupus cohorts, Innovative trials and new opportunities in SLE, Classification and diagnosis of SLE, and� Updates on SLE Treatment.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Interferons in Systemic Lupus ErythematosusNeutrophil Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus
The Power of Systems Biology: Insights on Lupus Nephritis from the Accelerating Medicines Partnership
Patient-Reported Outcomes in Lupus
T Cells in Systemic Lupus Erythematosus
B Cells in Systemic Lupus Erythematosus: From Disease Mechanisms to Targeted Therapies
Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials
Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus
Management of Pregnancy in Lupus
Lupus Cohorts
Innovative Trials and New Opportunities in SLE
Systemic Lupus Erythematosus Classification and Diagnosis
Treatment Update in Systemic Lupus Erythematous
Authors
Zahi Touma Assistant Professor of Medicine, University of Toronto; Clinician Scientist, Krembil Research InstituteToronto, Ontario, Canada. Alfred Kim
